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INTRODUCTION
Epidemiological studies in northern Greece have
been performed in a healthy population showing
seroprevalence to Bartonella henselae and Bartonella
quintana ranging from 15.9% to 19.8%, and from
13.6% to 15%, respectively [1]. Cases of cat
scratch disease (CSD) have been reported that
concern only children [2]. In this article, we report
and analyse 107 cases of CSD in northern Greece.
MATERIALS AND METHODS
Between 2000 and 2006, we examined paired serum samples
from 1107 patients (522 adults and 585 children) suspected of
having CSD, because of lymphadenopathy or fever of
unknown origin, fever and rash, infectious endocarditis, and
neurological and ocular manifestations. The referring doctors
were requested to provide the following information: contact
with an animal, clinical signs and symptoms, physical ﬁnd-
ings, and the histopathological results in the cases where a
lymph node biopsy had been performed.
Five hundred and sixty-four patients (217 adults and 347
children) appeared with typical clinical manifestations of
regional lymphadenopathy. Furthermore, 268 patients (100
adults and 168 children) presented with fever of unknown
origin, 138 (71 adults and 67 children) with fever and rash, 27
(24 adults and three children) with pneumonia, 33 adults with
neurological symptoms, and 34 adults with ocular manifesta-
tions. Additionally, samples of 43 adults suffering from
culture-negative endocarditis were also tested serologically.
All sera were examined using both the B. henselae ⁄ quintana
IgG ⁄ IgM indirect immunoﬂuorescent test (Focus kit) according
to the manufacturer’s instructions. A serological diagnosis was
made on the basis of either titres of IgM antibodies ‡1 : 20 or
IgG antibodies ‡1 : 256, or the presence of a four-fold rise in
the IgG titre between the acute phase and convalescent phase.
All sera were also tested for Coxiella burnetii, Anaplasma
phagocytophilum, Rickettsia typhi, Rickettsia conorii, Chlamydia
spp., cytomegalovirus, Epstein–Barr virus, Toxoplasma gondii,
inﬂuenza viruses A and B, parainﬂuenza viruses, respiratory
syncytial virus, Mycoplasma pneumoniae and Legionella pneumo-
phila to exclude cross-reactions.
RESULTS
In 107 patients, the serological diagnosis of
B. henselae infection was conﬁrmed. Sixty-seven
patients (29 adults and 38 children) presented
typical clinical manifestations of CSD, with
regional lymphadenopathy and fever. Fifteen of
29 adults and 18 of 38 children reported contact
with cats. In two cases, contact with dogs was also
reported. In ﬁve patients, the histological exam-
ination of lymph nodes provided histopatholog-
ical ﬁndings compatible with CSD. The most
common site of swollen lymph nodes was the
neck (36 cases), followed by the axilla (25 cases),
the inguinal region (three cases), and the sub-
mandibular region (three cases).
In 12 patients with fever of unknown origin
(four adults and eight children), the serological
diagnosis of Bartonella infection was also estab-
lished. Furthermore, four patients (three adults
and one child) with fever and rash, four adults
with pneumonia, three patients with neurological
symptoms and ﬁve patients with ocular manifes-
tations showed high titres to Bartonella or sero-
conversion. In six patients with culture-negative
endocarditis, an association of their illness with
B. quintana infection was strongly suspected, on
the basis only of serological criteria.
DISCUSSION
Among the 18 recognized and validated species
included in the genus Bartonella, at least 14 are
human pathogens. As they cause a wide spectrum
of clinical manifestations, there is an increasing
interest in Europe concerning Bartonella infections
[3]. CSD typically presents with a localized
lymphadenopathy with a brief period of fever
and general symptoms. However, there are atyp-
ical cases with a wide spectrum of clinical man-
ifestations, including prolonged fever, or systemic
complications, without lymphadenopathy.
In this study, 107 positive cases were evaluated.
The indentiﬁed clinical manifestations were sim-
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ilar to those reported from other countries.
Regional lymphadenopathy, the most common
clinical feature of CSD, was noted in 67 (62%) of
the 107 cases. Fever of unknown origin lasting for
more than 15 days as a unique symptom
appeared in 11.8% of the conﬁrmed cases of
CSD, covering 4.5% of all the examined patients
with fever of unknown origin. These ﬁndings
support previous studies showing that B. henselae
infection is the third most common cause,
accounting for 4.8% of the cases among patients
with fever of unknown origin. Other manifesta-
tions, such as as neurological and ocular mani-
festations, fever with rash, and pneumonia, were
associated with Bartonella infection at lower
frequencies.
Bartonella spp. were ﬁrst reported to cause
endocarditis as early as 1993, and subsequent
cases have been reported from the USA, France,
Canada, South Africa, and the UK. More recently,
sporadic cases have been reported in other Euro-
pean countries. Bartonella was estimated to cause
3% of all cases of endocarditis in Canada and
France and 28% of cases of blood culture-negative
infective endocarditis in France, a percentage that
is highly similar to our data, even though in our
investigation no molecular methods were used, as
serum samples were the only samples sent to
laboratory by the physicians.
The involvement of cats in the epidemiology of
the disease is strongly suspected in Greece, as in
33 of the 101 diagnosed cases, both typical and
atypical, contact with cats was reported. Two
cases were associated with dogs. In the other
cases, the route of infection was unknown. Before
1995, clinical diagnosis fulﬁlling three of the four
criteria for CSD was difﬁcult, because skin test
solution was not readily available, and biopsy, a
painful and invasive procedure, was difﬁcult to
perform. In addition, it was difﬁcult to diagnose a
CSD case lacking lymphadenophathy without a
reliable diagnostic test. The development of an
indirect immunoﬂuorescence assay for the detec-
tion of antibodies against Bartonella spp. has
greatly enhanced serological diagnosis [4].
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